13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$214.3M
$214.3M
36 檔
36.9%
The Q1 2025 SEC filing reveals that Knoll Capital Management, LLC held a total portfolio value of $214.3M, covering 36 public equity positions.
Knoll Capital Management, LLC executed strategic sector rebalancing during Q1 2025, establishing 23 new positions while fully exiting 29 holdings and trimming 2 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 20.48% | +0.30% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 12.99% | +5.40% | +9.27% | |
| 3 | ✓ | Entera Bio LTD | Stock-Other | 6.50% | +1.27% | — | |
| 4 | GLD | Spdr Gold Shares | ETF-Commodities | 6.00% | — | — | |
| 5 | MGTX | MeiraGTx Holdings plc | Stock-Other | 5.51% | +1.87% | — | |
| 6 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 3.91% | -2.12% | — | |
| 7 | ALT | Altimmune Inc | Stock-Other | 3.65% | -0.04% | — | |
| 8 | KGC | Kinross Gold CORP | Stock-Materials | 3.61% | -1.89% | — | |
| 9 | AYS1 | Sandstorm Gold LTD | Stock-Other | 3.44% | — | — | |
| 10 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 3.06% | — | — | |
| 11 | OCUL | Ocular Therapeutix Inc | Stock-Other | 2.86% | +2.45% | — | |
| 12 | FNV | Franco-nevada CORP | Stock-Materials | 2.56% | -1.28% | — | |
| 13 | ELTX | Elicio Therapeutics Inc | Stock-Other | 2.53% | -1.53% | — | |
| 14 | APLT | Applied Therapeutics Inc | Stock-Other | 2.48% | — | +34.48% | |
| 15 | EQX | Equinox Gold CORP | Stock-Other | 2.47% | — | — | |
| 16 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 2.41% | -1.18% | — | |
| 17 | SKE | Skeena Resources LTD | Stock-Other | 2.07% | — | — | |
| 18 | MQ8 | Mag Silver CORP | Stock-Other | 1.69% | — | — | |
| 19 | SLV | Ishares Silver Trust | ETF-Commodities | 1.61% | — | — | |
| 20 | NUVB | Nuvation Bio Inc | Stock-Other | 1.17% | +0.67% | — | |
| 21 | V | Visa Inc-class A Shares | Stock-Financials | 1.11% | — | — | |
| 22 | PM | Philip Morris International | Stock-Consumer Staples | 1.03% | -0.08% | — | |
| 23 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 0.88% | +2.10% | — | |
| 24 | RGLD | Royal Gold Inc | Stock-Materials | 0.80% | -2.54% | — | |
| 25 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.76% | -0.06% | — | |
| 26 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.72% | -0.31% | — | |
| 27 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.71% | -0.52% | — | |
| 28 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.63% | -0.25% | — | |
| 29 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.46% | — | — | |
| 30 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.38% | — | — | |
| 31 | CDE | Coeur Mining Inc | Stock-Materials | 0.37% | -0.27% | — | |
| 32 | ✓ | Hookipa Pharma | Stock-Other | 0.35% | — | — | |
| 33 | NEWP | New Pacific Metals CORP | Stock-Other | 0.35% | -0.20% | — | |
| 34 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 0.29% | — | -96.48% | |
| 35 | ✓ | Orgenesis, Inc. | Stock-Other | 0.08% | -0.01% | — | |
| 36 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.06% | -0.07% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALDX | Aldeyra Therapeutics Inc | +17.1% | — | Add |
| 2 | AEM | Agnico Eagle Mines LTD | +3.7% | — | Add |
| 3 | ALT | Altimmune Inc | +3.1% | — | Add |
| 4 | EQX | Equinox Gold CORP | +2.3% | — | Add |
| 5 | FNV | Franco-nevada CORP | +2.3% | — | Add |
| 6 | SEA1EUR | Seabridge Gold Inc | +2.1% | — | Add |
| 7 | MQ8 | Mag Silver CORP | +1.5% | — | Add |
| 8 | V | Visa Inc-class A Shares | +0.5% | — | Unchanged |
| 9 | BAH | Booz Allen Hamilton Holdings | +0.3% | — | Unchanged |
| 10 | ✓ | Entera Bio LTD | -1.3% | — | Add |
| 11 | ✓ | Orgenesis, Inc. | -3.4% | — | Trim |
| 12 | APLT | Applied Therapeutics Inc | -8.7% | +34.48% | Add |
| 13 | BHVN | Biohaven Ltd. | -30.5% | +9.27% | Trim |
| 14 | CRBPEUR | Corbus Pharmaceuticals Holdi | — | EXIT | Sold out |
| 15 | GLD | Spdr Gold Shares | — | NEW | New buy |
| 16 | MGTX | MeiraGTx Holdings plc | — | NEW | New buy |
| 17 | CLDNEUR | Eiger Biopharmaceuticals Inc | — | EXIT | Sold out |
| 18 | KGC | Kinross Gold CORP | — | NEW | New buy |
| 19 | AYS1 | Sandstorm Gold LTD | — | NEW | New buy |
| 20 | ✓ | Anavex Life Sciemves Corp | — | EXIT | Sold out |
| 21 | ✓ | Avadel Pharmaceuticals PLC ADR | — | NEW | New buy |
| 22 | ABEO1EUR | Abeona Therapeutics Inc | — | EXIT | Sold out |
| 23 | OCUL | Ocular Therapeutix Inc | — | NEW | New buy |
| 24 | ELTX | Elicio Therapeutics Inc | — | NEW | New buy |
| 25 | ANVS | Annovis Bio | — | EXIT | Sold out |
| 26 | SKE | Skeena Resources LTD | — | NEW | New buy |
| 27 | CTLEUR | Centurylink Inc | — | EXIT | Sold out |
| 28 | BXUSD | Blackstone Group Lp/the | — | EXIT | Sold out |
| 29 | SLV | Ishares Silver Trust | — | NEW | New buy |
| 30 | XCUR | Exicure Inc | — | EXIT | Sold out |
| 31 | DOW | Dow Inc | — | EXIT | Sold out |
| 32 | NUVB | Nuvation Bio Inc | — | NEW | New buy |
| 33 | PM | Philip Morris International | — | NEW | New buy |
| 34 | CTVA | Corteva Inc | — | EXIT | Sold out |
| 35 | ANETEUR | Arista Networks Inc | — | EXIT | Sold out |
| 36 | RGLD | Royal Gold Inc | — | NEW | New buy |
| 37 | CVS | Cvs Health CORP | — | EXIT | Sold out |
| 38 | ITA | Ishares U.s. Aerospace & Def | — | NEW | New buy |
| 39 | 6D8 | Dupont De Nemours Inc | — | EXIT | Sold out |
| 40 | AMD | Advanced Micro Devices | — | EXIT | Sold out |
| 41 | VMWEUR | Vmware Inc-class A | — | EXIT | Sold out |
| 42 | NOC | Northrop Grumman CORP | — | NEW | New buy |
| 43 | AGI | Alamos Gold Inc-class A | — | NEW | New buy |
| 44 | GLW | Corning Inc | — | EXIT | Sold out |
| 45 | MO | Altria Group Inc | — | EXIT | Sold out |
| 46 | TMO | Thermo Fisher Scientific Inc | — | EXIT | Sold out |
| 47 | WPM | Wheaton Precious Metals CORP | — | NEW | New buy |
| 48 | ✓ | Soligenix Inc | — | EXIT | Sold out |
| 49 | ✓ | Angion BioMedica Corp | — | EXIT | Sold out |
| 50 | DEO | Diageo Plc-sponsored Adr | — | NEW | New buy |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $214.3M across 36 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALDX, BHVN, ENTERA BIO LTD) accounted for 36.9% of total reported equity market value during Q1 2025.
Top New Position Initiated
GLD
市值: $9.2M
Top Position Liquidated / Trimmed
CRBPEUR
前期市值: $9.2M
During Q1 2025, Knoll Capital Management, LLC's top holdings by market value included ALDX (20.5%)、BHVN (13.0%)、ENTERA BIO LTD (6.5%). The largest single position, ALDX, represented 20.5% of total portfolio value.
In Q1 2025, Knoll Capital Management, LLC made 63 total portfolio adjustments, initiating 23 new buys, adding to 9 positions, trimming 2 holdings, and fully liquidating 29 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.